| |
| Device | Multi-Target Stool DNA (mtsDNA) Test, Cologuard Plus™ |
| Generic Name | System, colorectal neoplasia, DNA methylation and hemoglobin detection |
| Applicant | Exact Sciences Corporation 5505 Endeavor Ln. Madision, WI 53719 |
| PMA Number | P230043 |
| Date Received | 12/22/2023 |
| Decision Date | 10/03/2024 |
| Product Code |
PHP |
| Docket Number | 24M-4797 |
| Notice Date | 10/16/2024 |
| Advisory Committee |
Pathology |
| Clinical Trials | NCT04144738
|
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement A qualitative in vitro diagnostic test intended for the detection of colorectal neoplasia-associated DNA markers and for the presence of occult hemoglobin in human stool. The Cologuard Plus test is performed on samples collected using the Cologuard Plus Collection Kit. A positive result may indicate the presence of colorectal cancer (CRC) or advance precancerous lesions (APL) and should be followed by a colonoscopy. The Cologuard Plus test is indicated to screen adults 45 years or older who are at average risk for CRC. The Cologuard Plus test is not a replacement for diagnostic colonoscopy in high-risk individuals. The Cologuard Plus test is performed at Exact Sciences, Madison, WI. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Supplements: |
S001 S003 S008 S009 S002 S004 S010 S005 S006 S007 |